GE and Surgi-Vision sign marketing agreement

Article

General Electric Medical Systems has entered into a marketing and distribution agreement with Surgi-Vision, a manufacturer of specialized MR coils used to take images from inside the body. Last year, Surgi-Vision received 510(k) clearance from the Food

General Electric Medical Systems has entered into a marketing and distribution agreement with Surgi-Vision, a manufacturer of specialized MR coils used to take images from inside the body. Last year, Surgi-Vision received 510(k) clearance from the Food and Drug Administration for clinical use of a new coil to image the esophagus and aorta. The coil will be distributed exclusively with the GE Signa CV/I MRI scanner, which images the heart and blood vessels.

Future products from Surgi-Vision will provide high-resolution images of the heart, urethra, and prostate. The new technology for the coils was developed at the Johns Hopkins University Department of Radiology. Doctors will now be able to explore intravascular plaques through the use of MR technology in a noninvasive procedure, said Dennis Cooke, global general manager of GE’s MR business.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.